Pharmacology of perilymph production.
D000086:Acetazolamide / Q000494:pharmacology; D000142:Acidosis, Respiratory / Q000150:complications; D000255:Adenosine Triphosphate / Q000494:pharmacology / Q000627:therapeutic use; D000418:Albumins / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D003911:Dextrans / Q000494:pharmacology / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000494:pharmacology / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000494:pharmacology / Q000627:therapeutic use; D004427:Ear Diseases / Q000188:drug therapy; D007758:Ear, Inner / Q000187:drug effects; D004976:Ethacrynic Acid / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D006168:Guinea Pigs; D007761:Labyrinthine Fluids / Q000378:metabolism*; D009540:Nicotinyl Alcohol / Q000494:pharmacology / Q000627:therapeutic use; D010208:Papaverine / Q000494:pharmacology / Q000627:therapeutic use; D010498:Perilymph / Q000187:drug effects / Q000378:metabolism*
D000418:Albumins; D003911:Dextrans; D004088:Dihydroergotoxine; D004087:Dihydroergotamine; D005665:Furosemide; D000255:Adenosine Triphosphate; D009540:Nicotinyl Alcohol; D010208:Papaverine; D004976:Ethacrynic Acid; D000086:Acetazolamide